Skip to main content
Advertisement
  • Loading metrics

DOGS: Reaction-Driven de novo Design of Bioactive Compounds

  • Markus Hartenfeller,

    Affiliation Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Zürich, Switzerland

  • Heiko Zettl,

    Affiliation Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Zürich, Switzerland

  • Miriam Walter,

    Affiliation Goethe-University, Institute of Pharmaceutical Chemistry, LiFF/OSF/ZAFES, Frankfurt am Main, Germany

  • Matthias Rupp,

    Affiliation Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Zürich, Switzerland

  • Felix Reisen,

    Affiliation Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Zürich, Switzerland

  • Ewgenij Proschak,

    Affiliation Goethe-University, Institute of Pharmaceutical Chemistry, LiFF/OSF/ZAFES, Frankfurt am Main, Germany

  • Sascha Weggen,

    Affiliation Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany

  • Holger Stark,

    Affiliation Goethe-University, Institute of Pharmaceutical Chemistry, LiFF/OSF/ZAFES, Frankfurt am Main, Germany

  • Gisbert Schneider

    gisbert.schneider@pharma.ethz.ch

    Affiliation Swiss Federal Institute of Technology (ETH), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Zürich, Switzerland

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.